Mometasone, a corticosteroid used to treat conditions such as asthma and nasal allergies, has had its patents expire [1].
When Did Mometasone's Key Patents Expire?
The primary patents for mometasone furoate, the active ingredient in many mometasone-containing medications, have expired. For example, U.S. Patent No. 5,023,252, which was crucial for the original formulation of products like Nasonex, expired in 2015 [2]. DrugPatentWatch.com tracks these patent expiries, providing detailed timelines for various pharmaceutical products [1].
What Does Patent Expiry Mean for Mometasone?
Patent expiry generally opens the door for generic manufacturers to produce and market their own versions of the drug. This can lead to increased competition and lower prices for consumers [1].
Are There Generic Versions of Mometasone Available?
Yes, following patent expiries, generic versions of mometasone furoate nasal spray and other formulations have become available. These generics offer a more affordable alternative to the original branded products [3].
How Do Generic Mometasone Products Compare to Brand-Name Versions?
Generic drugs are required to be bioequivalent to their brand-name counterparts, meaning they contain the same active ingredient, dosage form, strength, and route of administration, and are proven to work in the same way [4]. Patients can expect similar therapeutic effects from generic mometasone as from branded versions.
What Medications Contain Mometasone?
Mometasone furoate is the active ingredient in several medications, including:
* Nasonex (nasal spray for allergies)
* Asmanex (inhaler for asthma)
* Elocon (topical cream, ointment, and lotion for skin conditions)
* Dulera (inhaler for asthma, in combination with formoterol fumarate)
[5, 6, 7]
Who Manufactures Mometasone Products?
Original mometasone products were developed and marketed by companies like Merck (Nasonex, Asmanex, Dulera) and Schering-Plough (later acquired by Merck) [5, 7]. Following patent expiry, numerous pharmaceutical companies now produce generic mometasone formulations [3].
What Are the Risks of Mometasone Use?
Like all corticosteroids, mometasone can have side effects. Common side effects of the nasal spray include headache, nosebleeds, and nasal irritation. Inhalers may cause sore throat or oral thrush. Topical formulations can lead to skin thinning or acne. It is important to discuss potential risks and side effects with a healthcare provider [8].
Can Doctors Still Prescribe Branded Mometasone After Patent Expiry?
Yes, physicians can still prescribe branded mometasone products. The decision to prescribe a brand-name or generic medication often depends on factors such as insurance coverage, patient preference, and physician recommendation [4].
---
Sources:
1. DrugPatentWatch.com. (n.d.). Retrieved from https://drugpatentwatch.com/
2. U.S. Patent No. 5,023,252. (1991).
3. U.S. Food and Drug Administration. (n.d.). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.
4. U.S. Food and Drug Administration. (n.d.). Generic Drugs: Frequently Asked Questions.
5. Merck & Co., Inc. (n.d.). Nasonex.
6. AstraZeneca. (n.d.). Asmanex.
7. U.S. Food and Drug Administration. (n.d.). Drug Approvals.
8. National Institutes of Health. (n.d.). Mometasone Topical.